BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

690 related articles for article (PubMed ID: 28689169)

  • 1. Leber congenital amaurosis/early-onset severe retinal dystrophy: clinical features, molecular genetics and therapeutic interventions.
    Kumaran N; Moore AT; Weleber RG; Michaelides M
    Br J Ophthalmol; 2017 Sep; 101(9):1147-1154. PubMed ID: 28689169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic and clinical findings in a Chinese cohort with Leber congenital amaurosis and early onset severe retinal dystrophy.
    Xu K; Xie Y; Sun T; Zhang X; Chen C; Li Y
    Br J Ophthalmol; 2020 Jul; 104(7):932-937. PubMed ID: 31630094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leber congenital amaurosis/early-onset severe retinal dystrophy: current management and clinical trials.
    Daich Varela M; Cabral de Guimaraes TA; Georgiou M; Michaelides M
    Br J Ophthalmol; 2022 Apr; 106(4):445-451. PubMed ID: 33712480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The phenotype of Severe Early Childhood Onset Retinal Dystrophy (SECORD) from mutation of RPE65 and differentiation from Leber congenital amaurosis.
    Weleber RG; Michaelides M; Trzupek KM; Stover NB; Stone EM
    Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):292-302. PubMed ID: 20811047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leber congenital amaurosis: Current genetic basis, scope for genetic testing and personalized medicine.
    Kondkar AA; Abu-Amero KK
    Exp Eye Res; 2019 Dec; 189():107834. PubMed ID: 31639339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Update on Gene Therapy for Inherited Retinal Dystrophy: Experience in Leber Congenital Amaurosis Clinical Trials.
    Chiu W; Lin TY; Chang YC; Isahwan-Ahmad Mulyadi Lai H; Lin SC; Ma C; Yarmishyn AA; Lin SC; Chang KJ; Chou YB; Hsu CC; Lin TC; Chen SJ; Chien Y; Yang YP; Hwang DK
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33926102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotyping and genotyping inherited retinal diseases: Molecular genetics, clinical and imaging features, and therapeutics of macular dystrophies, cone and cone-rod dystrophies, rod-cone dystrophies, Leber congenital amaurosis, and cone dysfunction syndromes.
    Georgiou M; Robson AG; Fujinami K; de Guimarães TAC; Fujinami-Yokokawa Y; Daich Varela M; Pontikos N; Kalitzeos A; Mahroo OA; Webster AR; Michaelides M
    Prog Retin Eye Res; 2024 May; 100():101244. PubMed ID: 38278208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and molecular findings in a cohort of 152 Brazilian severe early onset inherited retinal dystrophy patients.
    Sallum JMF; Motta FL; Arno G; Porto FBO; Resende RG; Belfort R
    Am J Med Genet C Semin Med Genet; 2020 Sep; 184(3):728-752. PubMed ID: 32865313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene Therapy in Hereditary Retinal Dystrophies: The Usefulness of Diagnostic Tools in Candidate Patient Selections.
    Malvasi M; Casillo L; Avogaro F; Abbouda A; Vingolo EM
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in RD3 are associated with an extremely rare and severe form of early onset retinal dystrophy.
    Preising MN; Hausotter-Will N; Solbach MC; Friedburg C; Rüschendorf F; Lorenz B
    Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):3463-72. PubMed ID: 22531706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extending the phenotypic spectrum of PRPF8, PRPH2, RP1 and RPGR, and the genotypic spectrum of early-onset severe retinal dystrophy.
    Georgiou M; Ali N; Yang E; Grewal PS; Rotsos T; Pontikos N; Robson AG; Michaelides M
    Orphanet J Rare Dis; 2021 Mar; 16(1):128. PubMed ID: 33712029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening of SPATA7 in patients with Leber congenital amaurosis and severe childhood-onset retinal dystrophy reveals disease-causing mutations.
    Mackay DS; Ocaka LA; Borman AD; Sergouniotis PI; Henderson RH; Moradi P; Robson AG; Thompson DA; Webster AR; Moore AT
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):3032-8. PubMed ID: 21310915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic and Clinical Profile of Retinopathies Due to Disease-Causing Variants in Leber Congenital Amaurosis (LCA)-Associated Genes in a Large German Cohort.
    Zobor D; Brühwiler B; Zrenner E; Weisschuh N; Kohl S
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRB1-Associated Retinal Dystrophies: Genetics, Clinical Characteristics, and Natural History.
    Daich Varela M; Georgiou M; Alswaiti Y; Kabbani J; Fujinami K; Fujinami-Yokokawa Y; Khoda S; Mahroo OA; Robson AG; Webster AR; AlTalbishi A; Michaelides M
    Am J Ophthalmol; 2023 Feb; 246():107-121. PubMed ID: 36099972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Available Evidence on Leber Congenital Amaurosis and Gene Therapy.
    Alkharashi M; Fulton AB
    Semin Ophthalmol; 2017; 32(1):14-21. PubMed ID: 27686653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy for Leber congenital amaurosis: advances and future directions.
    Hufnagel RB; Ahmed ZM; Corrêa ZM; Sisk RA
    Graefes Arch Clin Exp Ophthalmol; 2012 Aug; 250(8):1117-28. PubMed ID: 22644094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detailed clinical characterisation, unique features and natural history of autosomal recessive
    Fahim AT; Bouzia Z; Branham KH; Kumaran N; Vargas ME; Feathers KL; Perera ND; Young K; Khan NW; Heckenlively JR; Webster AR; Pennesi ME; Ali RR; Thompson DA; Michaelides M
    Br J Ophthalmol; 2019 Dec; 103(12):1789-1796. PubMed ID: 30979730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inherited retinal diseases: Therapeutics, clinical trials and end points-A review.
    Georgiou M; Fujinami K; Michaelides M
    Clin Exp Ophthalmol; 2021 Apr; 49(3):270-288. PubMed ID: 33686777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leber congenital amaurosis associated with AIPL1: challenges in ascribing disease causation, clinical findings, and implications for gene therapy.
    Tan MH; Mackay DS; Cowing J; Tran HV; Smith AJ; Wright GA; Dev-Borman A; Henderson RH; Moradi P; Russell-Eggitt I; MacLaren RE; Robson AG; Cheetham ME; Thompson DA; Webster AR; Michaelides M; Ali RR; Moore AT
    PLoS One; 2012; 7(3):e32330. PubMed ID: 22412862
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 35.